1. Home
  2. GPRE vs CRVS Comparison

GPRE vs CRVS Comparison

Compare GPRE & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Green Plains Inc.

GPRE

Green Plains Inc.

N/A

Current Price

$15.93

Market Cap

1.1B

Sector

Industrials

ML Signal

N/A

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$14.00

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRE
CRVS
Founded
2004
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2004
2016

Fundamental Metrics

Financial Performance
Metric
GPRE
CRVS
Price
$15.93
$14.00
Analyst Decision
Buy
Strong Buy
Analyst Count
7
6
Target Price
$12.57
$30.17
AVG Volume (30 Days)
1.4M
645.8K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
48.04
EPS
1.25
N/A
Revenue
$2,091,680,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$11.85
N/A
P/E Ratio
$12.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.65
$5.64
52 Week High
$19.65
$26.95

Technical Indicators

Market Signals
Indicator
GPRE
CRVS
Relative Strength Index (RSI) 53.90 45.80
Support Level $13.89 $12.76
Resistance Level $16.65 $14.00
Average True Range (ATR) 0.82 0.61
MACD 0.09 -0.07
Stochastic Oscillator 79.08 13.20

Price Performance

Historical Comparison
GPRE
CRVS

About GPRE Green Plains Inc.

Green Plains Inc manufactures and sells ethanol and ethanol byproducts in two segments based on function. The ethanol production segment, which generates the majority of revenue, includes the production of ethanol, distillers grains, Ultra-High Protein and renewable corn oil. The agribusiness and energy services segment includes grain handling and storage, commodity marketing and merchant trading for company-produced and third-party ethanol, distillers grains, Ultra-High Protein, renewable corn oil, natural gas and other commodities.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: